Page last updated: 2024-08-22

helenalin and Hepatocellular Carcinoma

helenalin has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, M; Fan, J; Gao, Q; Liu, LZ; Shi, JY; Song, FN; Wang, XY; Wang, ZC; Yang, LX; Zhou, J1

Other Studies

1 other study(ies) available for helenalin and Hepatocellular Carcinoma

ArticleYear
RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Antigens, CD; Antineoplastic Agents, Phytogenic; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Collagenases; Diffusion Chambers, Culture; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Invasiveness; NF-kappa B; Nuclear Proteins; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Sesquiterpenes; Sesquiterpenes, Guaiane; Signal Transduction; Snail Family Transcription Factors; Transcription Factors; Twist-Related Protein 1; Vimentin

2014